A key part of President Trump’s trade deal with China this past week: reopen the market for American soybeans. If you think ...

Full Measure is a weekly Sunday television news program focusing on investigative, original and accountability reporting. The managing editor and host is Sharyl Attkisson, five-time Emmy Award winner ...

Our history of manufacturing is marked by waves of innovation, decline, and revival. It’s shaped our national prosperity and ...

Full Measure is a weekly Sunday television news program focusing on investigative, original and accountability reporting. The managing editor and host is Sharyl Attkisson, five-time Emmy Award winner ...

Full Measure is a weekly Sunday television news program focusing on investigative, original and accountability reporting. The managing editor and host is Sharyl Attkisson, five-time Emmy Award winner ...

Mexico’s cartels are drowning in cash, fueled by record billions they got from smuggling drugs and people across our southern ...

Polls show that public trust in the scientific establishment has suffered immensely in the wake of Covid. That’s prompted many to ask questions about conflicts of interest. Today, with the help of a ...

Today we begin with an investigation regarding the Covid-19 vaccine shortages. There are serious questions about an incorrect claim made by top scientists at CDC: the nation’s premiere public health ...

In a shocking healthcare scheme under Obamacare, you paid $9000 a day, per addict, for months to put hundreds into luxury drug rehab. But not only did the patients not get treatment, some of them are ...

We begin with an amazing development on the energy front. Right now, some of the world’s leaders in green energy are reluctantly returning to fossil fuel in a big way. That’s because what some see as ...

The FBI has been mired in controversy. An FBI lawyer — caught doctoring documents to spy on a Donald Trump campaign supporter. Former FBI Director James Comey — given a pass after being referred for ...

Florida has just announced $60 Million to explore generics like ivermectin to fight cancer. Right now, generics don’t promise big profits, so their uses may go unstudied overlooked. Ivermectin, long ...